Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Abraham

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Current Oncology (Toronto, Ont.)|April 21, 2022
Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian PerspectiveCristiano Ferrario, Anna Christofides, Anil Abraham Joy, et al.
International Journal of Dermatology|June 26, 2014
Human papillomavirus vaccine acceptance among young men in Bangalore, IndiaHrishikesh Kumar Belani, Poorani Sekar, Rajarshi Guhaniyogi, et al.
International Journal of Dermatology|April 20, 2004
Cutaneous sporotrichosis in Bangalore, southern IndiaNagamani Mohan, Elizabeth Jayaseelan, Anil Abraham, et al.
International Journal of Dermatology|July 25, 2013
Disseminated cutaneous Ochroconis gallopava infection in an immunocompetent host: an unusual concurrence - a case report and review of cases reportedMuthu Sendhil Kumaran, Shuba Bhagwan, Jayanthi Savio, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigmCharlie Yang, Christine Brezden-Masley, Anil Abraham Joy, et al.
Clinical Breast Cancer|September 3, 2018
Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerVered Stearns, Adam M Brufsky, Shailendra Verma, et al.
The Oncologist|February 12, 2017
Predatory Invitations from Journals: More Than Just a Nuisance?Mark Clemons, Miguel de Costa E Silva, Anil Abraham Joy, et al.
Cureus|December 3, 2016
Factors Associated With the Use of Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer in Alberta, Canada: A Population-based StudyHong-Wei Liu, Marc Kerba, Gerald Lim, et al.
Therapeutic Advances in Medical Oncology|January 17, 2022
Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the linesChristine Simmons, Daniel Rayson, Anil Abraham Joy, et al.
BMC Medicine|May 11, 2023
Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosisJohn Walker, Anil Abraham Joy, Larissa J Vos, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Current Oncology (Toronto, Ont.)|April 21, 2022
Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian PerspectiveCristiano Ferrario, Anna Christofides, Anil Abraham Joy, et al.
International Journal of Dermatology|June 26, 2014
Human papillomavirus vaccine acceptance among young men in Bangalore, IndiaHrishikesh Kumar Belani, Poorani Sekar, Rajarshi Guhaniyogi, et al.
International Journal of Dermatology|April 20, 2004
Cutaneous sporotrichosis in Bangalore, southern IndiaNagamani Mohan, Elizabeth Jayaseelan, Anil Abraham, et al.
International Journal of Dermatology|July 25, 2013
Disseminated cutaneous Ochroconis gallopava infection in an immunocompetent host: an unusual concurrence - a case report and review of cases reportedMuthu Sendhil Kumaran, Shuba Bhagwan, Jayanthi Savio, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigmCharlie Yang, Christine Brezden-Masley, Anil Abraham Joy, et al.
Clinical Breast Cancer|September 3, 2018
Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerVered Stearns, Adam M Brufsky, Shailendra Verma, et al.
The Oncologist|February 12, 2017
Predatory Invitations from Journals: More Than Just a Nuisance?Mark Clemons, Miguel de Costa E Silva, Anil Abraham Joy, et al.
Cureus|December 3, 2016
Factors Associated With the Use of Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer in Alberta, Canada: A Population-based StudyHong-Wei Liu, Marc Kerba, Gerald Lim, et al.
Therapeutic Advances in Medical Oncology|January 17, 2022
Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the linesChristine Simmons, Daniel Rayson, Anil Abraham Joy, et al.
BMC Medicine|May 11, 2023
Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosisJohn Walker, Anil Abraham Joy, Larissa J Vos, et al.
Pageof 6